Fats
Fats are an essential class of macronutrients that, beyond providing the most concentrated energy (9 kcal/g), perform structural, transport, protective, and signalling functions: they build cell membranes, enable absorption of fat‑soluble vitamins, participate in thermoregulation and inflammation, and control appetite via the gut‑brain axis.
Fats as a Macronutrient
Main article: Fats as a Macronutrient: Definition and Physiological Functions
Fats (dietary lipids) are a class of macronutrients characterised by high energy density (37 kJ or 9 kcal/g), water insolubility, and diverse physiological functions that extend far beyond energy provision (EFSA 2010; Nordic Council of Ministers 2023).
Energy function – Fats are the body’s most concentrated energy reserve. Excess dietary triglycerides are stored in adipose tissue and mobilised during fasting, exercise or cold exposure. Fat also slows gastric emptying via cholecystokinin, prolonging satiety (Mozaffarian 2016; Retterstøl and Rosqvist 2024).
Structural function – Phospholipids derived from dietary fats form the bilayer of all cell membranes. Fatty acid unsaturation determines membrane fluidity, and cholesterol modulates stability. Lipids are essential for myelination of nerve fibres and for organelle integrity (Hirahatake et al. 2020; Nordic Council of Ministers 2023).
Transport function – Fats enable absorption of fat‑soluble vitamins (A, D, E, K) and carotenoids via mixed micelles. Absorbed lipids are packaged into chylomicrons and transported by lipoproteins in blood. Without dietary fat, bioavailability of these essential nutrients is severely impaired (EFSA 2010; Hirahatake et al. 2020).
Protective and thermoregulatory functions – Adipose tissue cushions internal organs, reduces friction (e.g., pericardial fat), and insulates against heat loss. Stored fat also fuels shivering and non‑shivering thermogenesis (Nordic Council of Ministers 2023).
Regulatory and signalling functions – Fatty acids act as ligands for nuclear receptors (PPARs), regulating genes for lipid and glucose metabolism. Arachidonic acid gives rise to eicosanoids; n‑3 PUFAs (EPA, DHA) are precursors for specialised pro‑resolving mediators (resolvins, protectins) that actively resolve inflammation. Fatty acids also modulate SREBPs, NF‑κB and endocannabinoid signalling (Poudyal and Brown 2015; Djuricic and Calder 2022; Anderson et al. 2025).
Digestive and satiety functions – Dietary fat triggers release of CCK, PYY and GLP‑1, slowing gastric emptying and signalling satiety via the gut‑brain axis. High energy density of fat contributes to passive overconsumption — a physical property, not a value judgement (Mozaffarian 2016; Nordic Council of Ministers 2023).
Conclusion – Fats are indispensable macronutrients. They provide concentrated energy, build all cell membranes, carry fat‑soluble vitamins, protect organs, insulate the body, regulate gene expression, and control appetite. A nutritionally adequate diet must include sufficient fat, not only to meet essential fatty acid requirements but also to support these broader physiological roles (Givens 2022; Siri‑Tarino et al. 2015).
Fatty Acids
Main article: Fatty Acids
Fatty acids are carboxylic acids with a hydrocarbon chain, serving as fundamental building blocks of most dietary lipids (Tvrzicka et al., 2011). Their chemical structure determines the physical properties of fats and their biological functions — from structural roles in membranes to involvement in signaling pathways.
Chemical Classification
By chain length:
- Short-chain (C2–C6), medium-chain (C6–C14), long-chain (C14–C21), very long-chain (≥C22) (Tvrzicka et al., 2011)
By saturation:
- *Saturated (SFA)* — no double bonds, tight packing, high melting points
- *Monounsaturated (MUFA)* — one double bond, creates a kink, lowers melting point
- *Polyunsaturated (PUFA)* — two or more double bonds, high fluidity, oxidation-sensitive (Tvrzicka et al., 2011)
By double bond position (omega families):
- *ω-6 (omega-6)* — first double bond at the 6th carbon from the methyl end
- *ω-3 (omega-3)* — first double bond at the 3rd carbon from the methyl end
- *ω-9 (omega-9)* — first double bond at the 9th carbon (endogenously synthesized)
Geometric isomerism:
- *Cis* configuration — hydrogen atoms on the same side of the double bond, creates a kink
- *Trans* configuration — hydrogen atoms on opposite sides, chain remains straight (Tvrzicka et al., 2011)
Essential Fatty Acids
Only two PUFAs are truly essential: linoleic acid (LA, 18:2ω-6) and α-linolenic acid (ALA, 18:3ω-3). They cannot be synthesized in the body and must come from the diet (Djuricic & Calder, 2021).
Conversion of ALA to long-chain ω-3 PUFAs in humans is limited: 5–10% converts to EPA, and less than 1% to DHA (Plourde & Cunnane, 2007).
Biological Functions
Structural role: Fatty acids serve as the hydrophobic tails of membrane phospholipids, determining membrane fluidity, thickness, and domain organization (Djuricic & Calder, 2021).
Energy substrate: Oxidation of fatty acids yields ~9 kcal/g. Carnitine palmitoyltransferase 1 is the rate-limiting enzyme of β-oxidation.
Signaling functions: Arachidonic acid (20:4ω-6) is a precursor of eicosanoids (prostaglandins, thromboxanes, leukotrienes). EPA and DHA are precursors of specialized pro-resolving mediators (resolvins, protectins, maresins) that actively resolve inflammation (Calder, 2017; Ishihara, Yoshida & Arita, 2019).
Receptor-mediated actions: Free fatty acids act as ligands for G-protein-coupled receptors: GPR40 (FFAR1) for medium- and long-chain FAs; GPR120 (FFAR4) for long-chain unsaturated FAs; GPR41/GPR43 for short-chain FAs (Birkeland et al., 2023; Ney et al., 2023).
Saturated Fatty Acids: Context Matters
The impact of SFA on cardiovascular risk depends on the replacement nutrient: replacing SFA with PUFA reduces cardiovascular events by ~30%, while replacing with carbohydrates does not (Hooper et al., 2020; Sacks et al., 2017). Food matrix also matters: dairy products (cheese, yogurt) are not associated with increased CVD risk despite their SFA content (Givens, 2022).
Lipid homeostasis: digestion, absorption and transport of dietary triglycerides (short version)
Main article: Lipid Homeostasis: Digestion, Absorption and Transport of Dietary Triglycerides
Dietary triacylglycerols (TAGs) constitute more than 90–95% of total fat intake and are highly hydrophobic. The human small intestine absorbs >95% of ingested TAGs through a complex multi‑step pathway involving emulsification, enzymatic lipolysis, enterocyte uptake, intracellular resynthesis, chylomicron assembly and lymphatic transport (IOM, 2005; Li et al., 2023).
Digestion: from emulsion to mixed micelles
In the duodenum, bile salts emulsify large lipid droplets, increasing the surface area for pancreatic lipase. Pancreatic lipase, together with its cofactor colipase, hydrolyses TAGs at the sn‑1 and sn‑3 positions, producing 2‑monoacylglycerols (2‑MAG) and free fatty acids (FFAs). These products are solubilised into mixed micelles, which transport them to the brush border membrane of jejunal enterocytes (Alfieri et al., 2017; Lema et al., 2020).
Enterocyte uptake: from micelle to cytosol
FFAs and 2‑MAG are taken up by a combination of passive diffusion and protein‑mediated transport. Key transporters include CD36 (FAT/SR‑B2), FATP4 and caveolin‑dependent endocytosis (Cifarelli & Abumrad, 2018). Inside the cytosol, long‑chain FFAs bind to FABP1 and FABP2, are activated to acyl‑CoA by ACSL enzymes, and are thus trapped inside the cell. Short‑ and medium‑chain fatty acids bypass this machinery and enter the portal circulation directly (Li et al., 2023).
Triglyceride resynthesis and lipid droplets
The dominant pathway during feeding is the monoacylglycerol pathway: 2‑MAG is sequentially acylated by MGAT (to diacylglycerol) and DGAT (to TAG). An alternative glycerol‑3‑phosphate pathway serves as a backup. A fraction of newly synthesised TAG is transiently stored in cytosolic lipid droplets coated with perilipin proteins (PLIN2), acting as a buffer against lipotoxicity and providing a mobilisable reservoir (Harayama & Shimizu, 2020; Li et al., 2023).
Chylomicron assembly
Chylomicrons are built around apolipoprotein B48 (apoB48). In the ER lumen, microsomal triglyceride transfer protein (MTP) transfers lipids to apoB48, forming a primordial particle that fuses with a large TAG droplet to create the pre‑chylomicron. This particle is transported to the Golgi via specialised pre‑chylomicron transport vesicles (PCTVs). PCTV budding requires a complex of FABP1, CD36, apoB48 and VAMP7, regulated by PKCζ‑dependent phosphorylation of Sar1b. In the Golgi, the chylomicron acquires apoA‑I and undergoes glycosylation, becoming mature (Cifarelli & Abumrad, 2018; Li et al., 2023).
Secretion into the lymphatic system
Mature chylomicrons are exocytosed at the basolateral membrane in a process requiring DENND5B and PLAGL2. They then cross the lamina propria and enter the lacteals – specialised lymphatic capillaries. Lacteal endothelial junctions exist as either permeable “button” junctions (which allow chylomicron passage) or tight “zipper” junctions. VEGF‑A/VEGFR2 signalling promotes zippering, while VEGF‑C/VEGFR3 maintains lacteal integrity. CD36 on lymphatic endothelium also contributes to barrier stability. From lacteals, chylomicrons flow through the lymphatic network, converge into the thoracic duct, and finally enter the venous circulation at the left subclavian vein (Lema et al., 2020; Li et al., 2023).
The intestinal absorption of dietary triglycerides is a highly efficient, redundant and adaptable system that integrates physical chemistry, membrane transport, enzymatic resynthesis and lymphatic biology. Understanding these fundamental processes provides the basis for interpreting how genetic variations and dietary fat composition influence lipid absorption without entering clinical or therapeutic discussions (IOM, 2005; Cifarelli & Abumrad, 2018; Li et al., 2023).
Dietary Sources of Fats: A Brief Overview of Classification by Origin and Processing
Main article: Dietary Sources of Fats: Classification by Origin and Technological Processing
Dietary fats are essential macronutrients, but understanding them requires more than analyzing isolated fatty acids. Modern nutritional science emphasizes that fats are consumed as part of complex food matrices that include proteins, carbohydrates, water, fiber, vitamins, minerals, and bioactive compounds such as polyphenols and phytosterols (Mozaffarian-2016; Givens-2022). This brief overview classifies dietary fats by two fundamental criteria: biological origin and technological processing, without providing clinical recommendations.
Classification by Origin
Animal Fats
- Dairy fat (milk, butter, cheese, yogurt): Contains diverse fatty acids including odd-chain saturated fatty acids (C15:0, C17:0) from rumen fermentation. The physical matrix varies dramatically between products (emulsion in milk, water-in-oil emulsion in butter, fat trapped in protein network in cheese), affecting digestibility (Duarte-2021; Nestel-2022).
- Meat fats (red meat, poultry): Primarily long-chain saturated (palmitic C16:0, stearic C18:0) and monounsaturated (oleic C18:1) fatty acids. Processed meats contain added sodium, nitrates, and other preservatives (Nagpal-2021).
- Seafood fats (fish oils): Rich in long-chain omega-3 polyunsaturated fatty acids (EPA, DHA), which originate from microalgae and accumulate up the marine food chain (Rizzo-2023).
- Rendered fats (tallow, lard, schmaltz): Produced by heating animal adipose tissue; stable at room temperature.
Vegetable Oils and Fats
- Non‑tropical oils (olive, rapeseed/canola, sunflower, soybean, flaxseed): High in unsaturated fatty acids (MUFA and PUFA), low in SFA (typically < 15–20%). Extra‑virgin olive oil retains high levels of polyphenols (Rosqvist-2024; Petersen-2024).
- Tropical oils (palm, palm kernel, coconut): High in saturated fatty acids (lauric, myristic, palmitic). Palm oil fractions (olein, stearin) differ markedly in fatty acid composition (Rosqvist-2024).
- Specialty nut and seed oils (walnut, hemp, echium, sacha inchi): Often contain unique fatty acid profiles, e.g., high alpha‑linolenic acid (ALA) or stearidonic acid (SDA) (Rizzo-2023).
Microbial and Alternative Sources
- Algal oils (from microalgae Schizochytrium, Crypthecodinium cohnii): Primary natural source of EPA and DHA; used in infant formula and supplements (Rizzo-2023).
- Fungal and yeast oils (single‑cell oils): Mortierella alpina produces arachidonic acid (AA).
- Genetically modified oilseed crops (transgenic Camelina sativa, canola, soybean): Engineered to produce EPA and DHA in seeds, offering a land‑based alternative to fish oil (Rizzo-2023).
Classification by Technological Processing
Minimally Processed (Natural). Mechanical extraction without heat or chemicals. Retains bioactive compounds (polyphenols, tocopherols, phytosterols). Examples: extra‑virgin olive oil, virgin coconut oil (Rosqvist-2024).
Refined Oils. Multi‑stage industrial process (degumming, neutralization, bleaching, deodorization) that removes impurities and produces neutral, stable oils with high smoke points. Most minor bioactive components are lost (Nagpal-2021).
Hydrogenation:
- Partial hydrogenation (historical): Converts liquid oils into semi‑solid fats but generates industrial trans fatty acids (elaidic acid), leading to global bans (Nagpal-2021; Oteng-2020).
- Full hydrogenation: Completely saturates double bonds; produces hard, waxy fats with no trans isomers.
Interesterification. Chemical or enzymatic rearrangement of fatty acids within triacylglycerols without changing overall fatty acid composition. Creates desired melting profiles and β’ crystal form without trans fats. Widely used in modern margarines and shortenings (Nagpal-2021).
Fractionation. Physical separation of fats into fractions with different melting points (e.g., palm olein vs. palm stearin). No chemical alteration (Rosqvist-2024).
Oleogels. Emerging technology using structuring agents (waxes, ethyl cellulose) to immobilize liquid oils in a gel network. Produces semi‑solid fats high in unsaturated fats and free of trans fats (Nagpal-2021).
Integrated Examples
- Butter vs. cheese: Same origin (cow’s milk), different processing and matrix – water‑in‑oil emulsion vs. fat trapped in protein network.
- Olive oil spectrum: Extra‑virgin → refined → pomace oil – same oleic acid dominance, but vastly different content of polyphenols and other minor components.
- Solid baking fats: Historically partially hydrogenated oils → now interesterified blends → emerging oleogels – three different technological routes for the same functional category.
- Margarine vs. butter: Margarine is an engineered emulsion, butter has a fixed animal fat matrix (Rosqvist-2024; Nagpal-2021).
Key Takeaways
- Avoid reductionism. Fatty acid profile alone does not define a fat’s nature; the food matrix and processing history are equally important.
- Processing is a continuum, not a binary (“natural” vs. “processed”).
- Whole foods and dietary patterns are the focus of modern nutritional science, not isolated nutrients.
- Open questions remain: long‑term effects of interesterified fats, role of minor components (polyphenols, phytosterols), sustainability of algal oils and GM crops, and evidence gaps for many specific fats (e.g., canola oil, palm fractions, coconut oil, margarines) (Rosqvist-2024; Rizzo-2023).
Thermal Stability of Dietary Fats: Key Processes and Quality Indicators (Short Version)
Main article: Thermal Stability of Dietary Fats: Processes of Oxidation, Smoke Formation, and Degradation
Frying at high temperatures (150–190 °C) induces a complex set of chemical reactions in culinary oils, leading to their degradation. The thermal stability of an oil is primarily determined by its fatty acid composition. Saturated fatty acids (SFAs) are highly resistant, monounsaturated fatty acids (MUFAs) are moderately stable, and polyunsaturated fatty acids (PUFAs) are highly susceptible to oxidation (Retterstøl & Rosqvist, 2024; Abrante-Pascual et al., 2024).
Main Degradation Pathways
1. Thermo-oxidation – A free-radical chain reaction generating hydroperoxides that rapidly decompose into secondary products such as aldehydes, ketones, and alcohols. PUFA-rich oils (e.g., sunflower, corn) produce aldehydes much faster than MUFA-rich oils (e.g., olive oil) (Grootveld, 2022). The process includes initiation (alkyl radical formation), propagation (peroxyl radicals), and termination (non-radical products including polymers).
2. Polymerisation – Alkyl and alkoxyl radicals combine to form dimers, oligomers, and polymers. These high‑molecular‑weight compounds increase oil viscosity, cause foaming, darken the oil, and reduce heat transfer efficiency (Abrante-Pascual et al., 2024; Bazina et al., 2025).
3. Hydrolysis – Moisture from food cleaves ester bonds of triacylglycerols, producing free fatty acids (FFAs), diacylglycerols, and monoacylglycerols. FFAs lower the smoke point and act as pro‑oxidants (Díez-Betriu et al., 2025; Kupikowska-Stobba et al., 2025).
4. Isomerisation – At very high temperatures (>200 °C), cis double bonds may convert to trans fatty acids (TFAs). TFAs are more stable and accumulate during prolonged frying (Nagpal et al., 2021; Abrante-Pascual et al., 2024).
5. Epoxy‑fatty acid formation – Epoxides arise from peroxyl radical attack or hydroperoxide decomposition. They are found in used frying oils at concentrations up to several grams per kilogram (Grootveld, 2022).
Smoke Formation
Smoke is composed of condensed volatile products: short‑chain aldehydes (acrolein, formaldehyde), low‑molecular‑weight FFAs, and other decomposition products. The smoke point is the temperature at which a continuous stream of smoke appears. It is strongly influenced by FFA content: higher FFAs lower the smoke point (Díez-Betriu et al., 2025). However, the smoke point is an incomplete degradation indicator because it does not reflect non‑volatile polar compounds or polymer accumulation (Bazina et al., 2025).
Factors Affecting Thermal Stability
Intrinsic factors: fatty acid profile (PUFA > MUFA > SFA in susceptibility), natural antioxidants (tocopherols, polyphenols – thermolabile), pro‑oxidants (transition metals, chlorophyll) (Flori et al., 2019; Retterstøl & Rosqvist, 2024).
Extrinsic factors: temperature (rate doubles per ~10 °C rise), frying duration and cycles, oxygen exposure, food moisture, food debris, fryer design (surface‑to‑volume ratio), and oil replenishment rate (Bazina et al., 2025; Kupikowska-Stobba et al., 2025).
Quality Control Methods
- Rapid in‑kitchen tests: visual colour, odour, smoke point observation, foaming, viscosity (qualitative, low sensitivity).
- Chemical tests: free fatty acid (FFA) content (titration or test strips), p‑anisidine value (secondary oxidation), total polar compounds (TPC) – the “gold standard” for discard decisions (typically discard at 24–25 % TPC) (Abrante-Pascual et al., 2024; Bazina et al., 2025).
- Advanced instrumental methods: gas chromatography (GC‑MS) for aldehydes and TFAs, high‑performance liquid chromatography (HPLC) for polar compounds, size‑exclusion chromatography (SEC) for polymers, and proton NMR for comprehensive fingerprinting (Díez-Betriu et al., 2025; Grootveld, 2022).
Thermal degradation of frying oils is a multifactorial process dominated by fatty acid composition and processing conditions. Oils rich in MUFAs (e.g., olive, high‑oleic sunflower) offer better stability than PUFA‑rich oils. Regular monitoring using TPC or FFA, together with good frying practices (moderate temperature, frequent filtration, oil replenishment), is essential for maintaining food quality and safety. No single test perfectly captures all aspects of degradation; a combination of methods is recommended.
Key Quantitative Norms for Dietary Lipids: A Summary
Main article: Quantitative Norms for Lipid Intake: Energy Contribution, Minimum Threshold, and Distribution in the Diet
Total Fat: Reference Intake Ranges
Dietary fat recommendations are expressed as a percentage of total energy intake (E%), not as absolute grams, because energy requirements vary by age, sex, physical activity level (PAL), and body size (EFSA, 2010). Major authoritative guidelines provide the following ranges for healthy adults:
- EFSA (2010): 20–35 E% (reference intake range) – based on nutritional adequacy, blood lipid profiles, and prevention of excess energy intake.
- Nordic Nutrition Recommendations 2023 (NNR2023): 25–40 E% (25–35 E% for less active individuals) – higher upper bound reflects higher habitual physical activity in Nordic populations and emphasis on fat quality (Nordic Council of Ministers, 2023; Retterstøl & Rosqvist, 2024).
- World Health Organization (WHO, 2023): ≤30 E% (conditional recommendation) – primary endpoint is prevention of unhealthy weight gain, based on a systematic review of RCTs (Hooper et al., 2020).
These differences are not contradictions but reflect different primary endpoints (blood lipids vs. body weight), target populations, and evidence bases. All guidelines agree that fat quality (replacing saturated and trans fats with unsaturated fats) is more important than strict quantity.
Lower Threshold: Preventing Inadequacy
A lower bound exists to prevent three forms of nutritional inadequacy (EFSA, 2010; Nordic Council of Ministers, 2023):
- Essential polyunsaturated fatty acids: Linoleic acid (LA, n‑6) – Adequate Intake (AI) 4 E%; α‑linolenic acid (ALA, n‑3) – AI 0.5 E%.
- Fat‑soluble vitamin absorption (A, D, E, K): requires dietary fat for mixed micelle formation.
- Energy density for young children: higher growth demands and small stomach capacity.
Quantitative lower bounds:
- Adults: ≥20 E% (EFSA) or ≥25 E% (NNR for less active). WHO states adults need at least 15–20 E% for adequacy (WHO, 2023).
- Infants (6–11 months) and young children (12–23 months): ≥30 E% (NNR2023). Intakes below 25 E% in this age group have been associated with low vitamin levels (EFSA, 2010).
Distribution Across Age Groups
Fat requirements are highest in infancy and gradually decline (Nordic Council of Ministers, 2023; EFSA, 2010).
| Age group | Recommended total fat (E%) | Notes |
|---|---|---|
| 0–6 months | ~50–55 (breast milk) | Adequate Intake; exclusive breastfeeding recommended |
| 6–11 months | 30–45 | Higher lower bound for rapid growth and brain development |
| 12–23 months | 30–40 | Gradual decline |
| 2–3 years | 30–40 | Target ~35 E% for planning |
| 4–10 years | 25–40 | Progressive decline towards adult range |
| 11–17 years | 25–40 | Adult range applies |
| Adults (18–70 years) | 20–35 (EFSA) / 25–40 (NNR) | Adjust for PAL; less active → lower end |
| Elderly (>70 years) | 25–40 (same as adults) | Prevent unintended weight loss; no reduction |
| Pregnancy/lactation | Same E% as non‑pregnant | Absolute fat intake (g) increases with higher energy needs |
Fatty Acid Classes Within the Total Fat Budget
Quantitative targets for fatty acid classes are interdependent because their sum equals total fat intake (E%) (EFSA, 2010; Nordic Council of Ministers, 2023).
- Saturated fatty acids (SFA): Upper limit < 10 E% (as low as possible within a nutritionally adequate diet). No lower bound; not essential.
- Trans fatty acids (TFA): Upper limit < 1 E% (as low as possible). No nutritional benefit.
- Polyunsaturated fatty acids (PUFA): Total 5–10 E%.
- LA (n‑6): AI 4 E%
- ALA (n‑3): AI 0.5 E%
- EPA + DHA: AI 250 mg/day for adults (EFSA, 2010); for infants (6–24 months) AI 100 mg/day DHA (NNR2023).
- Monounsaturated fatty acids (MUFA): No direct target; calculated by difference: MUFA (E%) = Total fat (E%) − SFA (E%) − PUFA (E%) − TFA (E%).
This energy budget approach ensures that when total fat is within the recommended range and SFA/TFA are limited, the diet automatically provides adequate essential PUFA and a favourable proportion of MUFA.
Methodological Basis
Quantitative norms are derived from a hierarchy of evidence (EFSA, 2010; WHO, 2023; Christensen et al., 2020):
- Balance and depletion‑repletion studies for essential fatty acids.
- Controlled feeding trials and meta‑analyses (e.g., Mensink et al., 2003) for dose–response effects on blood lipids.
- Long‑term randomised controlled trials (e.g., Hooper et al., 2020) for cardiovascular events and body weight.
- Prospective cohort studies for dose–response and generalisability.
- Systematic reviews (e.g., de Souza et al., 2015) synthesise evidence; expert panels apply GRADE or similar frameworks.
Differences between guidelines (e.g., 35% vs. 40% upper bound) reflect different primary endpoints, population characteristics, and practical considerations, not fundamental scientific disagreement.
Key Practical Messages
- No single “correct” fat percentage. Optimal intake depends on age, physical activity, body weight, and diet quality.
- Lowering total fat without improving fat quality is not beneficial. Replacing SFA and TFA with unsaturated fats (vegetable oils, nuts, seeds, fatty fish) is the priority.
- Very low‑fat diets (< 15–20 E%) carry risks of essential fatty acid deficiency, impaired vitamin absorption, and, in children, inadequate energy intake.
- Active individuals can tolerate higher fat intakes (up to 35–40 E%) because higher energy expenditure allows more grams of fat within the same E% range.
- Infants and young children need a higher lower bound (30 E%) to support growth and neurodevelopment.
For detailed dose–response relationships and age‑specific reference values, see the original guidelines (EFSA, 2010; Nordic Council of Ministers, 2023; WHO, 2023).
Dietary Fats: From Demonization to Rehabilitation – A Concise Summary
Main article: The Evolution of Dietary Fat Recommendations: From Demonization to Rehabilitation of Triglycerides
For decades, dietary fat—particularly saturated fat—was portrayed as a primary cause of cardiovascular disease (CVD). This view, rooted in the “diet‑heart hypothesis” of Ancel Keys, led to decades of low‑fat recommendations (Menotti & Puddu, 2025). However, accumulating evidence has forced a fundamental re‑evaluation. This brief summary highlights key turning points and modern conclusions.
Origins of the Diet‑Heart Hypothesis (1950s–1970s)
Ancel Keys’ Seven Countries Study reported strong ecological correlations between saturated fatty acid (SFA) intake and coronary heart disease (CHD) mortality (Menotti & Puddu, 2025). Early metabolic ward experiments showed that SFAs raise serum LDL cholesterol, while polyunsaturated fats (PUFA) lower it (Sacks et al., 2017). The first randomized controlled trials (RCTs) – the Los Angeles Veterans Study, Oslo Diet‑Heart, MRC soybean oil trial, and Finnish Mental Hospital Study – appeared to support the hypothesis, although they had serious methodological limitations, including use of trans‑fat‑rich margarines (Sacks et al., 2017; Astrup et al., 2020).
By 1977, the US Senate McGovern Report set a target of ≤10% of calories from saturated fat, and the 1980 Dietary Guidelines for Americans advised “avoid too much fat, saturated fat, and cholesterol” (Astrup et al., 2021).
Apogee of Low‑Fat Dogma and the Rise of Carbohydrates (1980s–2000s)
The 1992 USDA Food Guide Pyramid placed fats at the apex and grains (6–11 servings/day) at the base, reinforcing the low‑fat message (Ludwig et al., 2018). Consumers and food manufacturers replaced fat with refined carbohydrates – white bread, white rice, cereals, and added sugars – often without improving health outcomes (Mozaffarian, 2016).
The Women’s Health Initiative (WHI), the largest dietary RCT ever conducted (nearly 49,000 women), found no benefit of a low‑fat diet on CVD events or mortality, despite a significant reduction in total and saturated fat intake (Sacks et al., 2017). This was a major blow to the low‑fat paradigm.
The critical insight emerged: replacement matters. Replacing SFA with PUFA reduces CVD, but replacing SFA with refined carbohydrates does not – and may even increase risk (Hooper et al., 2020). Carbohydrate quality (glycaemic index, fibre content) became recognised as equally important as fat quality (Ludwig et al., 2018).
Paradigm Crisis and First Steps to Rehabilitation (2010s)
Large meta‑analyses of prospective cohorts found no significant association between SFA intake and CHD or CVD (Siri‑Tarino et al., 2010; Chowdhury et al., 2014, cited in Givens, 2022). Re‑analysis of old RCTs (Minnesota Coronary Experiment, Sydney Diet Heart Study) showed no benefit – or even harm – but these studies were confounded by industrial trans fats (Astrup et al., 2020).
The global PURE study (135,335 participants, 18 countries) reported that higher SFA intake was associated with lower total mortality and stroke, while higher carbohydrate intake was associated with higher total mortality (Dehghan et al., 2017, cited in Astrup et al., 2020).
Several paradoxes undermined the simple “SFA → LDL → CVD” chain:
- SFA raises LDL but also raises HDL and lowers triglycerides, improving the total cholesterol:HDL ratio – a stronger risk predictor than LDL alone (Mente et al., 2017, cited in Givens, 2022).
- SFA predominantly increases large, buoyant LDL particles, which are weakly atherogenic, while high carbohydrate intake produces small, dense LDL particles that are highly atherogenic (Bergeron et al., 2019, cited in Givens, 2022).
- De novo lipogenesis: a high‑carbohydrate, low‑fat diet increases endogenous synthesis of palmitic acid (16:0), the very SFA that guidelines aim to avoid (Volk et al., 2014, cited in Astrup et al., 2020).
The 2020 Cochrane review concluded that reducing SFA “probably makes little or no difference to all‑cause mortality” and “probably makes little or no difference to cardiovascular mortality”, though it reduces combined CVD events when replaced by PUFA (Hooper et al., 2020).
The Food Matrix: Key to the Puzzle (2015–present)
Cheese and butter contain similar amounts of SFA, yet cheese does not raise LDL cholesterol as butter does. Explanation: calcium in cheese forms insoluble fatty acid soaps, reducing absorption; the solid protein matrix slows digestion (Givens, 2022). Yogurt and fermented dairy are associated with lower type 2 diabetes risk, an effect not explained by fat content (Mozaffarian, 2016). Dark chocolate (rich in stearic acid) is neutral or beneficial (Astrup et al., 2020). Unprocessed red meat has weak or null associations with CVD, whereas processed meat (high sodium, nitrates) is clearly harmful (Mozaffarian, 2016).
Thus, the food matrix – the three‑dimensional structure and composition of whole foods – fundamentally modifies the metabolic effects of fatty acids. Dietary guidelines must move from nutrient‑based to food‑based recommendations.
Modern Consensus and Remaining Questions
Consensus:
- Total dietary fat should not be restricted (upper limit of 35% removed in 2015 DGAC report).
- Replace SFA with PUFA (e.g., soybean, canola oil) or high‑quality carbohydrates (whole grains, legumes), not with refined starches and sugars.
- The 10% SFA cap is a rough guideline, not a strict threshold; context (dietary pattern, food matrix) matters.
- Industrial trans fats should be eliminated; natural ruminant trans fats are not a concern at typical intakes.
Remaining questions:
- Optimal SFA intake likely varies by population (PURE suggests up to 13–14% may be safe).
- Long‑term safety of very low‑carbohydrate, high‑fat (ketogenic) diets is unknown.
- Personalised nutrition: LDL response to SFA varies greatly between individuals; baseline LDL, triglycerides, and genotype (e.g., APOE4) may predict responsiveness (Griffin & Lovegrove, 2024). The RISSCI studies aim to identify simple biomarkers for personalised advice.
- Food system interventions (e.g., modifying dairy fat composition by feeding cows high‑oleic oils; incorporating legume flour into bread) can improve population health without relying on individual behaviour change (Lovegrove, 2025).
Key Messages for the Public
1. Do not fear dietary fat. Fat is an essential macronutrient. The low‑fat era was based on incomplete evidence.
2. Focus on foods, not nutrients. Whole‑fat dairy, unprocessed meat, dark chocolate can be part of a healthy diet when consumed in moderation.
3. Replace, don’t just reduce. Replace saturated fat with unsaturated fats (olive oil, nuts, avocado) or high‑quality carbohydrates (whole grains, legumes), not with refined starches and sugars.
4. Beware of processing. Cheese is not butter; unprocessed meat is not processed meat; virgin coconut oil is not highly refined coconut oil.
5. Ignore hype. No single food is a “superfood” or a “poison”. The overall dietary pattern matters far more than any single ingredient.
The history of dietary fat recommendations is a case study in how science self‑corrects. A plausible hypothesis became a rigid dogma, then was challenged by better evidence. Today, we understand that SFA is neither a poison nor a health food. Its effects depend on chain length, food matrix, replacement nutrient, and individual metabolism. The simple message “fat is bad” is dead. The new consensus – “eat real food, mostly plants, not too much, and enjoy the diversity of nature’s fats” – is more complex but closer to the truth.
References
- Abrante-Pascual, S., Nieva-Echevarria, B. and Goicoechea-Oses, E. (2024) ‘Vegetable Oils and Their Use for Frying: A Review of Their Compositional Differences and Degradation’, Foods, 13(24), p. 4186. DOI: 10.3390/foods13244186 PubMed
- Alfieri, A., Imperlini, E., Nigro, E., Vitucci, D., Orrù, S., Daniele, A., Buono, P. and Mancini, A. (2017) ‘Triacylglycerols and Interesterified Fats: Role in Fasting and Postprandial Lipemia’, Molecules, 22(1): 31. DOI: 10.3390/ijms19010104 PubMed
- Anderson, K. C., Liu, J. and Liu, Z. (2025) ‘Interplay of fatty acids, insulin and exercise in vascular health’, Lipids in Health and Disease, 24, p. 4. DOI: 10.1186/s12944-024-02421-5 PubMed
- Astrup, A., Magkos, F., Bier, D.M., Brenna, J.T., de Oliveira Otto, M.C., Hill, J.O., King, J.C., Mente, A., Ordovas, J.M., Volek, J.S., Yusuf, S. and Krauss, R.M. (2020) 'Saturated Fats and Health: A Reassessment and Proposal for Food-Based Recommendations: JACC State-of-the-Art Review', Journal of the American College of Cardiology, 76(7), pp. 844-857. DOI: 10.1016/j.jacc.2020.05.077 PubMed
- Astrup, A., Teicholz, N., Magkos, F., Bier, D.M., Brenna, J.T., King, J.C., Mente, A., Ordovas, J.M., Volek, J.S., Yusuf, S. and Krauss, R.M. (2021) 'Dietary Saturated Fats and Health: Are the U.S. Guidelines Evidence-Based?', Nutrients, 13, 3305. DOI: 10.3390/nu13103305 PubMed
- Bazina, N., Ahmed, T., Almadaaf, M., Abu Hallalah, H.M.O. and Jibia, S. (2025) ‘Chemical Changes in Deep-Fat Frying: Reaction Mechanisms, Oil Degradation, and Health Implications’, Food Science & Nutrition. DOI: 10.1002/fsn3.70969 PubMed
- Birkeland, E., Gharagozlian, S., Valeur, J. and Aas, A.-M. (2023) ‘Short-chain fatty acids as a link between diet and cardiometabolic risk: a narrative review’, Lipids in Health and Disease, 22, 40. DOI: 10.1186/s12944-023-01803-5 PubMed
- Calder, P.C. (2017) ‘Omega-3 fatty acids and inflammatory processes: from molecules to man’, Biochemical Society Transactions, 45(5), pp. 1105–1115. DOI: 10.1042/BST20160474 PubMed
- Cifarelli, V. and Abumrad, N.A. (2018) ‘Intestinal CD36 and Other Key Proteins of Lipid Utilization: Role in Absorption and Gut Homeostasis’, Comprehensive Physiology, 8(2): 493–507. DOI: 10.1002/cphy.c170026 PubMed
- Díez-Betriu, A., Quintanilla-Casas, B., Masdemont, J.J., Tres, A., Vichi, S. and Guardiola, F. (2025) ‘Deciphering the Complexity of Smoke Point in Virgin Olive Oils to Develop Simple Predictive Models’, Foods, 14(23), p. 4099. DOI: 10.3390/foods14234099 PubMed
- Djuricic, I. and Calder, P.C. (2021) ‘Beneficial Outcomes of Omega-6 and Omega-3 Polyunsaturated Fatty Acids on Human Health: An Update for 2021’, Nutrients, 13(7), 2421. DOI: 10.3390/nu13072421 PubMed
- Djuricic, I. and Calder, P. C. (2022) ‘Polyunsaturated fatty acids and metabolic health: novel insights’, Current Opinion in Clinical Nutrition and Metabolic Care. DOI: 10.1097/MCO.0000000000000865 PubMed
- Duarte, C., Boccardi, V., Amaro Andrade, P., Souza Lopes, A. C., & Jacques, P. F. (2021). ‘Dairy versus other saturated fats source and cardiometabolic risk markers: Systematic review of randomized controlled trials’. Critical Reviews in Food Science and Nutrition, 61(3), 450-461. DOI: 10.1080/10408398.2020.1736509 PubMed
- EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2010) ‘Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol’, EFSA Journal, 8(3), p. 1461. DOI: 10.2903/j.efsa.2010.1461
- Flori, L., Testai, L., Calderone, V., Flori, L.,... and Venturi, F. (2019) ‘The Nutraceutical Value of Olive Oil and Its Bioactive Constituents on the Cardiovascular System. Focusing on Main Strategies to Slow Down Its Quality Decay during Production and Storage’, Nutrients, 11(9), p. 2192. DOI: 10.3390/nu11091962 PubMed
- Givens, D. I. (2022) ‘Saturated fats, dairy foods and cardiovascular health: No longer a curious paradox?’, Nutrition Bulletin, 47, pp. 407–422. DOI: 10.1111/nbu.12585 PubMed
- Griffin, B.A. and Lovegrove, J.A. (2024) ‘Saturated fat and CVD: importance of inter‑individual variation in the response of serum low‑density lipoprotein cholesterol’, Proceedings of the Nutrition Society, 83, 87–96. DOI: 10.1017/S0029665124000107 PubMed
- Grootveld, M. (2022) ‘Evidence-Based Challenges to the Continued Recommendation and Use of Peroxidatively-Susceptible Polyunsaturated Fatty Acid-Rich Culinary Oils for High-Temperature Frying Practises: Experimental Revelations Focused on Toxic Aldehydic Lipid Oxidation Products’, Frontiers in Nutrition, 8, p. 711640. DOI: 10.3389/fnut.2021.711640 PubMed
- Harayama, T. and Shimizu, T. (2020) ‘Roles of polyunsaturated fatty acids, from mediators to membranes’, Journal of Lipid Research, 61(8): 1150–1160. DOI: 10.1194/jlr.R120000800 PubMed
- Hirahatake, K. M., Bruno, R. S., Bolling, B. W., Blesso, C., Alexander, L. M. and Adams, S. H. (2020) ‘Dairy Foods and Dairy Fats: New Perspectives on Pathways Implicated in Cardiometabolic Health’, Advances in Nutrition, 11, pp. 266–279. DOI: 10.1093/advances/nmz105 PubMed
- Hooper, L., Martin, N., Jimoh, O.F., Kirk, C., Foster, E. and Abdelhamid, A.S. (2020) ‘Reduction in saturated fat intake for cardiovascular disease’, Cochrane Database of Systematic Reviews, Issue 5, CD011737. DOI: 10.1002/14651858.CD011737.pub2 PubMed
- Institute of Medicine (IOM) (2005) Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, DC: The National Academies Press. DOI: 10.17226/10490
- Ishihara, T., Yoshida, M. and Arita, M. (2019) ‘Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis’, International Immunology, 31(9), pp. 559–567. DOI: 10.1093/intimm/dxz001 PubMed
- Kupikowska-Stobba, B., Niu, H., Klojodva, I., Agregán, R., Lorenzo, J.M. and Kasprzak, M. (2025) ‘Controlled lipid digestion in the development of functional and personalized foods for a tailored delivery of dietary fats’, Food Chemistry, 466, p. 142151. DOI: 10.1016/j.foodchem.2024.142151 PubMed
- Lema, I., Araujo, J.R., Rolhion, N. and Demignot, S. (2020) ‘Jejunum: the understudied meeting place of dietary lipids and the microbiota’, Biochimie, 178: 124–136. DOI: 10.1016/j.biochi.2020.09.007 PubMed
- Li, X., Liu, Q., Pan, Y., Chen, S., Zhao, Y. and Hu, Y. (2023) ‘New insights into the role of dietary triglyceride absorption in obesity and metabolic diseases’, Frontiers in Pharmacology, 14: 1097835. DOI: 10.3389/fphar.2023.1097835 PubMed
- Lovegrove, J.A. (2025) ‘Dietary fats and cardiometabolic health-from public health to personalised nutrition: 'One for all' and 'all for one'’, Nutrition Bulletin, 50, pp. 132–141. DOI: 10.1111/nbu.12722 PubMed
- Ludwig, D.S., Willett, W.C., Volek, J.S. and Neuhouser, M.L. (2018) 'Dietary fat: From foe to friend?', Science, 362(6416), pp. 764-770. DOI: 10.1126/science.aau2096 PubMed
- Ma, Y., Zhang, Z., Zhang, L., Wang, H., Chen, L. and Liu, L. (2024) ‘Dietary Macronutrient Intake and Cardiovascular Disease Risk and Mortality: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies’, Nutrients, 16(1), p. 152. DOI: 10.3390/nu16010152 PubMed
- Menotti, A. and Puddu, P.E. (2025) 'Ancel Keys, the Mediterranean Diet, and the Seven Countries Study: A Review', Journal of Cardiovascular Development and Disease, 12, 141. DOI: 10.3390/jcdd12040141 PubMed
- Mozaffarian, D. (2016) ‘Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity’, Circulation, 133, pp. 187–225. DOI: 10.1161/CIRCULATIONAHA.115.018585
- Nagpal, T., Sahu, J. K., Khare, S. K., Bashir, K., & Jan, K. (2021). ‘Trans fatty acids in food: A review on dietary intake, health impact, regulations and alternatives’. Journal of Food Science, 86(11), 1-16. DOI: 10.1111/1750-3841.15977 PubMed
- Nestel, P. J., & Mori, T. A. (2022). ‘Dairy Foods: Is Its Cardiovascular Risk Profile Changing?’. Current Atherosclerosis Reports, 24(1), 33-40. DOI: 10.1007/s11883-022-00984-1 PubMed
- Ney, L.-M., Wipplinger, M., Grossmann, M., Engert, N., Wegner, V.D. and Mosig, A.S. (2023) ‘Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections’, Open Biology, 13, 230014. DOI: 10.1098/rsob.230014 PubMed
- Nordic Council of Ministers (2023) Nordic Nutrition Recommendations 2023: Integrating Environmental Aspects, ed. Blomhoff, R., Andersen, R., Arnesen, E. K., Christensen, J. J., Eneroth, H., Erkkola, M., Gudanaviciene, I., Halldórsson, Þ. I., Høyer-Lund, A., Lemming, E. W., Meltzer, H. M., Pitsi, T., Schwab, U., Siksna, I., Thorsdottir, I. and Trolle, E. Copenhagen: Nordic Council of Ministers. DOI: 10.6027/nord2023-003
- Oteng, A.-B., & Kersten, S. (2020). ‘Mechanisms of Action of trans Fatty Acids’. Advances in Nutrition, 11(3), 697-708. DOI: 10.1093/advances/nmz125 PubMed
- Petersen, K. S., Maki, K. C., Calder, P. C., Belury, M. A., Messina, M., Kirkpatrick, C. F., & Harris, W. S. (2024). ‘Perspective on the health effects of unsaturated fatty acids and commonly consumed plant oils high in unsaturated fat’. British Journal of Nutrition, 132(8), 1039-1050? DOI: 10.1017/S0007114524002459 PubMed
- Plourde, M. and Cunnane, S.C. (2007) ‘Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements’, Applied Physiology, Nutrition, and Metabolism, 32(4), pp. 619–634. DOI: 10.1139/H07-034 PubMed
- Poudyal, H. and Brown, L. (2015) ‘Should the pharmacological actions of dietary fatty acids in cardiometabolic disorders be classified based on biological or chemical function?’, Progress in Lipid Research, 59, pp. 172–200. DOI: 10.1016/j.plipres.2015.07.002 PubMed
- Retterstøl, K. and Rosqvist, F. (2024) ‘Fat and fatty acids - a scoping review for Nordic Nutrition Recommendations 2023’, Food & Nutrition Research, 68, p. 9980. DOI: 10.29219/fnr.v68.9980 PubMed
- Rizzo, G., Baroni, L., & Lombardo, M. (2023). ‘Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review’. International Journal of Environmental Research and Public Health, 20(3), 1683. DOI: 10.3390/ijerph20031683 PubMed
- Rosqvist, F., & Niinistö, S. (2024). ‘Fats and oils - a scoping review for Nordic Nutrition Recommendations 2023’. Food & Nutrition Research, 68. DOI: 10.29219/fnr.v68.10487 PubMed
- Sacks, F.M., Lichtenstein, A.H., Wu, J.H.Y., Appel, L.J., Creager, M.A., Kris-Etherton, P.M., Miller, M., Rimm, E.B., Rudel, L.L., Robinson, J.G., Stone, N.J. and Van Horn, L.V. (2017) ‘Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association’, Circulation, 136, e1–e23. DOI: 10.1161/CIR.0000000000000510 PubMed
- Saini, R.K. and Keum, Y.-S. (2018) ‘Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance - A review’, Life Sciences, 203: 255–267. DOI: 10.1016/j.lfs.2018.04.049 PubMed
- Schwingshackl, L., Zähringer, J., Beyerbach, J., Werner, S.S., Nagavci, B., Heseker, H., Koletzko, B. and Meerpohl, J.J. (2021) ‘A Scoping Review of Current Guidelines on Dietary Fat and Fat Quality’, Annals of Nutrition and Metabolism, 77, pp. 65–82. DOI: 10.1159/000515671 PubMed
- Srnic, N., Westcott, F., Caney, E. and Hodson, L. (2025) ‘Dietary fat quantity and composition influence hepatic lipid metabolism and metabolic disease risk in humans’, Disease Models & Mechanisms, 18: dmm050878. DOI: 10.1242/dmm.050878 PubMed
- Tvrzicka, E., Kremmyda, L.-S., Stankova, B. and Zak, A. (2011) ‘Fatty acids as biocompounds: their role in human metabolism, health and disease--a review. Part 1: classification, dietary sources and biological functions’, Biomedical Papers, 155(2), pp. 117–130. DOI: 10.5507/bp.2011.038 PubMed
- U.S. Department of Agriculture and U.S. Department of Health and Human Services. (2025). Dietary Guidelines for Americans, 2025-2030. 9th Edition. (официальный документ)
- World Health Organization (WHO) (2023) Total fat intake for the prevention of unhealthy weight gain in adults and children: WHO guideline. Geneva: World Health Organization. ISBN 978-92-4-007365-4. Available at: www: int/publications/i/item/9789240073654.
- Wu, H., Xu, L. and Ballantyne, C.M. (2020) ‘Dietary and Pharmacological Fatty Acids and Cardiovascular Health’, The Journal of Clinical Endocrinology & Metabolism, 105(4): 1030–1045. DOI: 10.1210/clinem/dgz174 PubMed
